China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Patient Journeys of Metastatic NSCLC Survivors Post-Five Years of Initial Immunotherapy: a retrospective observational study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130473
Registration Time: 2026/08/20
Type: Observational study
Primary Sponsor: Peking Union Medical College Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=302161
Published by HT Digital Content Services with permission from Health Daily Digest....